Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Bitsatab Mekasha"'
Autor:
Hailemichael Desalegn, Hanna Aberra, Nega Berhe, Girmay Medhin, Bitsatab Mekasha, Svein Gunnar Gundersen, Asgeir Johannessen
Publikováno v:
BMC Gastroenterology, Vol 19, Iss 1, Pp 1-7 (2019)
Abstract Background Antiviral treatment for chronic hepatitis B (CHB) is largely unavailable in sub-Saharan Africa; hence, little is known about the prognosis after initiating treatment in African CHB patients. In this study we aimed to assess predic
Externí odkaz:
https://doaj.org/article/4b6ebe2fc8a24d73a1150d0f1d725fd4
Autor:
Hailemichael Desalegn, Hanna Aberra, Nega Berhe, Bitsatab Mekasha, Kathrine Stene-Johansen, Henrik Krarup, Andre Puntervold Pereira, Svein Gunnar Gundersen, Asgeir Johannessen
Publikováno v:
BMC Medicine, Vol 16, Iss 1, Pp 1-10 (2018)
Abstract Background The World Health Organization has set an ambitious goal of eliminating viral hepatitis as a major public health threat by 2030. However, in sub-Saharan Africa, antiviral treatment of chronic hepatitis B (CHB) is virtually unavaila
Externí odkaz:
https://doaj.org/article/35f017cf32b1478796531c416ff56f8f
Autor:
Asgeir Johannessen, Bitsatab Mekasha, Hailemichael Desalegn, Hanna Aberra, Kathrine Stene-Johansen, Nega Berhe
Publikováno v:
Vaccines, Vol 9, Iss 5, p 430 (2021)
High viral load and positive hepatitis B e-antigen (HBeAg) results are risk factors for mother-to-child transmission (MTCT) of hepatitis B virus (HBV). In sub-Saharan Africa, little is known about the distribution of these risk factors, as well as ea
Externí odkaz:
https://doaj.org/article/631629e6f8e24fe7aa9c6836445bcd8e
Autor:
Nega Berhe, Hailemichael Desalegn, Asgeir Johannessen, Bitsatab Mekasha, Hanna Aberra, Svein Gunnar Gundersen, Girmay Medhin
Publikováno v:
Journal of Hepatology. 70:1065-1071
Background & Aims In 2015, the World Health Organization (WHO) issued guidelines for the management of chronic hepatitis B (CHB) in low- and middle-income countries, but little is known about the applicability of the WHO treatment criteria in sub-Sah
Autor:
Hailemichael Desalegn, Nega Berhe, Kathrine Stene-Johansen, Asgeir Johannessen, Bitsatab Mekasha, Hanna Aberra
Publikováno v:
Vaccines
Volume 9
Issue 5
Vaccines, Vol 9, Iss 430, p 430 (2021)
Volume 9
Issue 5
Vaccines, Vol 9, Iss 430, p 430 (2021)
High viral load and positive hepatitis B e-antigen (HBeAg) results are risk factors for mother-to-child transmission (MTCT) of hepatitis B virus (HBV). In sub-Saharan Africa, little is known about the distribution of these risk factors, as well as ea
Autor:
Nega Berhe, Hailemichael Desalegn, Asgeir Johannessen, Hanna Aberra, Bitsatab Mekasha, Girmay Medhin, Svein Gunnar Gundersen
Publikováno v:
BMC Gastroenterology
BMC Gastroenterology, Vol 19, Iss 1, Pp 1-7 (2019)
BMC Gastroenterology, Vol 19, Iss 1, Pp 1-7 (2019)
Background Antiviral treatment for chronic hepatitis B (CHB) is largely unavailable in sub-Saharan Africa; hence, little is known about the prognosis after initiating treatment in African CHB patients. In this study we aimed to assess predictors of m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f084cdda70bfaa1477291a8129b41bd
https://hdl.handle.net/11250/2649268
https://hdl.handle.net/11250/2649268
Autor:
Nega Berhe, Kathrine Stene-Johansen, Asgeir Johannessen, Hanna Aberra, Svein Gunnar Gundersen, Henrik Krarup, Andre Puntervold Pereira, Hailemichael Desalegn, Bitsatab Mekasha
Publikováno v:
Desalegn, H, Aberra, H, Berhe, N, Mekasha, B, Stene-Johansen, K, Krarup, H, Pereira, A P, Gundersen, S G & Johannessen, A 2018, ' Treatment of chronic hepatitis B in sub-Saharan Africa : 1-year results of a pilot program in Ethiopia ', BMC Medicine, vol. 16, no. 1, 234 . https://doi.org/10.1186/s12916-018-1229-x
BMC Medicine
BMC Medicine, Vol 16, Iss 1, Pp 1-10 (2018)
BMC Medicine
BMC Medicine, Vol 16, Iss 1, Pp 1-10 (2018)
Background The World Health Organization has set an ambitious goal of eliminating viral hepatitis as a major public health threat by 2030. However, in sub-Saharan Africa, antiviral treatment of chronic hepatitis B (CHB) is virtually unavailable. Here
Autor:
Asgeir Johannessen, Hanna Aberra, Hailemichael Desalegn, Bitsatab Mekasha, Emmanuel Gordien, Frédéric Le Gal, Athenaïs Gerber, Segolene Brichler, Kathrine Stene-Johansen, Nega Berhe
Publikováno v:
Journal of Hepatology. 70:e819-e820
Autor:
Andrew N Brown, Nana Am Essah, Sofia Kälvemark Sporrong, Janine Morgall Traulsen, Dawit Teshome Gebregeorgise, Bitsatab Mekasha Habtegiorgis, Sara A Khan, Woynabeba Damene Kabtimer
Publikováno v:
Rural and Remote Health.
Introduction The health supply chain is often the weakest link in achieving the health-related Millennium Development Goals and universal health coverage, requiring trained professionals who are often unavailable. In Ethiopia there have been recent d
Publikováno v:
Journal of Hepatology. 66:S470